Pfizer announced that it is “reviewing strategic alternatives” for its Consumer Healthcare business, the parent company of many iconic over-the-counter (OTC) brands from dietary supplements to personal care.
The NASDAQ-traded firm Innophos Holdings has entered into a definitive merger agreement to acquire Novel Ingredients for $125m, bumping up the share of its food, health, and nutrition segment within the company.
Investment interest in the dietary supplement industry remains high, with the latest news being the sale of majority control of The Nature’s Bounty Co. to private equity firm KKR.
Nutraceutical International Corporation’s longtime aggressive acquisition strategy has borne the ultimate fruit in the announcement today that the company will be sold to a private equity firm for $446 million.
Thanks to the increased popularity of turmeric and other botanical products in food and beverage, market analysts have seen an uptick of interest and familiarity for Ayurvedic ingredients outside of India, which has translated to increased activity for...
The US investment community has only a limited interest in investing in or acquiring dietary supplement brands, but interest in the sector from Chinese investors is expected to continue, says Nutrition Capital Network.
Dairy and nutritional ingredients firm Glanbia has confirmed two strategic acquisitions that will enhance its performance nutrition division by bringing a greater focus on plant-based foods and direct-to-consumer sales.
Reckitt Benckiser Group plc (RB) has confirmed it is in ‘advanced negotiations’ to acquire all Mead Johnson Nutrition shares for $90 each in cash, valuing Mead Johnson’s entire share capital at approximately $16.7bn.
i-Health Inc., a wholly owned subsidiary of Royal DSM, has entered into an agreement to purchase the UP4 Probiotic brand from Wisconsin-based UAS Laboratories.
Omega Protein has come through the tumult of a proxy fight and has announced a plan to distribute some of the cash generated by the business to shareholders via dividends. A line in the announcement gave the impression the company’s management has finally...
Private equity firm Everstone Group has acquired a significant minority stake in OmniActive Health Technologies to help OmniActive in diversifying and expanding its offerings.
